Extended follow-up of patients randomly assigned in the angiotensin-converting enzyme inhibition post-revascularization study (APRES)
To access this article, please choose from the options below
PII: S0002-8703(04)00192-9
doi:10.1016/j.ahj.2004.04.004
© 2004 Elsevier Inc. All rights reserved.
